Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Arcus Biosciences (RCUS) Return on Invested Capital (2021 - 2025)

Arcus Biosciences (RCUS) has 4 years of Return on Invested Capital data on record, last reported at 0.51% in Q3 2024.

  • For Q3 2024, Return on Invested Capital rose 9.0% year-over-year to 0.51%; the TTM value through Sep 2024 reached 0.51%, up 9.0%, while the annual FY2023 figure was 0.62%, 24.0% down from the prior year.
  • Return on Invested Capital reached 0.51% in Q3 2024 per RCUS's latest filing, down from 0.44% in the prior quarter.
  • Across five years, Return on Invested Capital topped out at 0.1% in Q3 2022 and bottomed at 0.71% in Q4 2023.
  • Average Return on Invested Capital over 4 years is 0.32%, with a median of 0.46% recorded in 2024.
  • Peak YoY movement for Return on Invested Capital: tumbled -71bps in 2023, then rose 10bps in 2024.
  • A 4-year view of Return on Invested Capital shows it stood at 0.08% in 2021, then crashed by -652bps to 0.42% in 2022, then plummeted by -70bps to 0.71% in 2023, then increased by 28bps to 0.51% in 2024.
  • Per Business Quant database, its latest 3 readings for Return on Invested Capital were 0.51% in Q3 2024, 0.44% in Q2 2024, and 0.47% in Q1 2024.